Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Dr Lal PathLabs acquires 80% of Sunshine Healthcare

PRIVATESep 26, 2026

Acquiring Company

Dr Lal PathLabs FZCO

Acquired Company

Sunshine Healthcare Limited

Dubai EmirateGhanaBiotechnologyHealth CareHealth CareMedical

Description

Dr Lal PathLabs FZCO has successfully acquired an 80% stake in Sunshine Healthcare Limited, strengthening its position in the African diagnostic market. This acquisition marks a crucial development in Dr Lal PathLabs' growth strategy within West Africa. With Sunshine now a significant subsidiary, Dr Lal PathLabs aims to enhance control over local operations and market access. The transaction was finalized following necessary regulatory approvals and compliance.

Company Information

Company

Dr Lal PathLabs FZCO

Location

Dubai Emirate, United Arab Emirates

About

Dr Lal PathLabs FZCO is a step-down subsidiary of Dr Lal PathLabs Limited, specializing in diagnostic services across multiple regions. The company is focused on expanding its reach in the healthcare sector, ensuring quality diagnostic solutions. It operates under the broader umbrella of its parent company, which is a leader in the Indian diagnostic market. The subsidiary aims to enhance its service offerings through strategic acquisitions.

Fundz sees it the moment Dr Lal PathLabs FZCO makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Dr Lal PathLabs FZCO's next move

Learn about Strategic plan

Frequently asked

Who acquired Sunshine Healthcare Limited?

Sunshine Healthcare Limited was acquired by Dr Lal PathLabs FZCO, based in Dubai Emirate. The deal was reported on September 26, 2026. Dr Lal PathLabs FZCO is a step-down subsidiary of Dr Lal PathLabs Limited, specializing in diagnostic services across multiple regions. Dr Lal PathLabs FZCO is privately held and operates in Biotechnology.

When did Dr Lal PathLabs FZCO acquire Sunshine Healthcare Limited?

Dr Lal PathLabs FZCO's acquisition of Sunshine Healthcare Limited was reported on September 26, 2026. Dr Lal PathLabs FZCO has successfully acquired an 80% stake in Sunshine Healthcare Limited, strengthening its position in the African diagnostic market. This acquisition marks a crucial development in Dr Lal PathLabs' growth strategy within West Africa. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Sunshine Healthcare Limited do?

Sunshine Healthcare Limited is a healthcare provider based in Ghana, focusing on delivering comprehensive diagnostic services. The company plays a vital role in the local healthcare infrastructure, working towards better health outcomes for the community. It is privately held, operating in Health Care, and is based in Ghana.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.